Stay updated on EDP-305 Safety and Efficacy in NASH Clinical Trial
Sign up to get notified when there's something new on the EDP-305 Safety and Efficacy in NASH Clinical Trial page.

Latest updates to the EDP-305 Safety and Efficacy in NASH Clinical Trial page
- Check4 days agoChange DetectedThe page now displays Revision: v3.6.5, signaling a newer site version, and the older Revision: v3.6.4 label has been removed.SummaryDifference18%

- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedThe page revision was updated from v3.6.3 to v3.6.4, indicating a minor update to the page’s documentation/version rather than to its content.SummaryDifference0.0%

- Check26 days agoChange DetectedFatty Liver Disease was replaced with Steatotic Liver Disease on the page to reflect updated nomenclature for liver fat–related conditions. This terminology change updates how the condition is described and searched within the study context.SummaryDifference0.0%

- Check40 days agoChange DetectedA new site revision label, v3.6.3, appears on the page. This indicates a platform update and does not modify the study details or user-facing actions.SummaryDifference0.0%

- Check47 days agoChange DetectedThe revision label was updated from v3.6.0 to v3.6.2, indicating a newer build of the site. This appears to be a deployment-level update rather than content changes on the page.SummaryDifference0.0%

- Check62 days agoChange DetectedRecruitment status updated to 'No longer looking for participants', and new help sections were added (How to Read a Study Record, Common Questions, How to Join a Study). A formatting change to the Intervention/Treatment heading and a revision version update from v3.5.5 to v3.6.0 were applied.SummaryDifference0.3%

Stay in the know with updates to EDP-305 Safety and Efficacy in NASH Clinical Trial
Enter your email address, and we'll notify you when there's something new on the EDP-305 Safety and Efficacy in NASH Clinical Trial page.